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MicroRNAs (miRNAs) are endogenously encoded single-stranded RNAs of about 22 nucleotides
(nts) in length that play essential roles in a large variety of physiological processes in animals and
plants (Ambros, 2004; Bushati and Cohen, 2007). Mature miRNAs are integrated into the RNA-
induced silencing complex (RISC), whose core component is one of the Argonaute family proteins.
MiRNAs then direct RISCs to target mRNAs, which are recognized through partial sequence
complementarity. Bioinformatic prediction and experimental target gene identification have shown
that a miRNA binds mRNAs of hundreds of protein coding genes, which often span a broad
spectrum of functional categories (Bartel, 2009; Chi et al., 2009; Hafner et al., 2010). The functional
consequence of miRNA-target mRNA interaction and the mechanism of miRNA action have been
under intensive investigation and remain a matter of hot debate. It was initially thought that
miRNAs repress the protein output of a small number of target genes without significantly affecting
their mRNA levels in animals (Lee et al., 1993; Wightman et al., 1993). Subsequent genetic studies
in C. elegans and zebrafish showed that miRNAs promote the degradation of their target mRNAs
(Bagga et al., 2005; Giraldez et al., 2006). Later, a series of genome-wide studies of in vitro cultured
mammalian cell lines transiently transfected with chemically synthesized miRNA mimics led to
the conclusion that the predominant functional consequence of miRNA action is target mRNA
degradation (Guo et al., 2010). A follow-up study employing temporal dissection of zebrafish
development seems to reconcile these two opposite observations by revealing that translational
repression precedes target mRNA decay, and suggesting that the immediate outcome of miRNA-
target mRNA interaction is translation inhibition but mRNA degradation can follow (Bazzini et al.,
2012). Similarly, re-analysis of the previous datasets from cultured cell lines transiently transfected
with synthetic miRNA mimics also found that translation repression precedes mRNA degradation
(Larsson and Nadon, 2013).
However, the model miRNA used in the aforementioned zebrafish study, miR-430, is unique in
that its expression is rapidly induced and reaches millions of copies per cell in a few hours after
fertilization. This expression level of miR-430 is at least 10 times more than all mature miRNAs
combined in amammalian cell, and serves the single purpose of degrading its target genes, maternal
mRNAs, at the maternal-zygotic transition (Giraldez et al., 2006). Mammalian cells often express
100–200 different species of miRNAs (Kuchen et al., 2010), with a total amount of 1–2 × 105
copies of mature miRNAs in a cell (Calabrese et al., 2007; Janas et al., 2012). The most abundant
miRNAs are often expressed at the level of ∼2 × 104 copies per cell (Neilson et al., 2007; Kuchen
et al., 2010). As an extreme example, miR-122 is expressed at the estimated level of 5 × 104 copies
per cell in hepatocytes (Chang et al., 2004; Jopling et al., 2005). This is still about 20 times lower
than the million-copy-per-cell expression level of miR-430 in zebrafish embryos. Considering that
the estimated copy number of Argonaute proteins in a mammalian cell is of the same order of
magnitude as the total amount of mature miRNAs (1.5 × 104–1.7 × 105; Janas et al., 2012; Wang
et al., 2012), the million-copy-per-cell expression level of miR-430 is unlikely to be physiologically
relevant in mammalian cells. Therefore, the in vivo mechanism of action of mammalian miRNAs
remains to be a central question in the field of miRNA research.
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In contrast to these desperate efforts to search for a unified
model of miRNA mechanism of action, studies of individual
functional targets in primary cells or tissues from miRNA
mutant mice are painting a rather different picture. Depending
on miRNAs, target genes, and cellular contexts, the outcome
of miRNA-target mRNA interactions could be predominantly
translation repression or mRNA degradation, or a mixture
of both. This heterogeneity in miRNA mechanisms of action
has been increasingly recognized as more and more miRNA
mutant mice are generated and analyzed (Olive et al., 2015),
but a comprehensive review of relevant literature is still
missing.
Here we sought to summarize the relative contribution
of translation repression and mRNA degradation to miRNA
regulation of functional targets in miRNA mutant mice. We
focused on miRNA target genes whose protein and mRNA levels
were measured concurrently in primary cells or tissues from
mutant mice with genetic ablation or transgenic expression of
individual miRNA genes. This includes a total of 159 target
genes from 77 miRNA mutant mice (Table S1; Zhao et al., 2005,
2007; Lu et al., 2007, 2009, 2014; van Rooij et al., 2007; Vigorito
et al., 2007; Dorsett et al., 2008; Liu et al., 2008, 2011, 2012,
2014; Wang et al., 2008, 2013a,b, 2014, 2015a,b; Boettger et al.,
2009; Callis et al., 2009; O’Connell et al., 2009, 2010; Poy et al.,
2009; Shan et al., 2009; Williams et al., 2009; Xin et al., 2009;
Miyaki et al., 2010; Patrick et al., 2010; Yu et al., 2010; Biton
et al., 2011; Boldin et al., 2011; Dunand-Sauthier et al., 2011;
Jiang et al., 2011; Jordan et al., 2011; Ma et al., 2011, 2013;
Nakamura et al., 2011; Sanuki et al., 2011; Shibata et al., 2011;
Aurora et al., 2012; Callegari et al., 2012; Caruso et al., 2012;
Dong et al., 2012; Gurha et al., 2012; Horie et al., 2012, 2013;
Hsu et al., 2012; Liang et al., 2012, 2015; Mori et al., 2012; Tsai
et al., 2012; Ucar et al., 2012; Wei et al., 2012, 2014; Zhuang
et al., 2012; Belkaya et al., 2013; Bian et al., 2013; Danielson
et al., 2013; Dorhoi et al., 2013; Dudda et al., 2013; Gebeshuber
et al., 2013; Guo et al., 2013; Hasuwa et al., 2013; Heidersbach
et al., 2013; Henao-Mejia et al., 2013; Khan et al., 2013; Mok
et al., 2013; Song et al., 2013, 2014; Stadthagen et al., 2013; Tan
et al., 2013; Wystub et al., 2013; Agudo et al., 2014; Ahmed et al.,
2014; Burger et al., 2014; Chapnik et al., 2014; Dahan et al., 2014;
Escobar et al., 2014; Giusti et al., 2014; Hu et al., 2014; Krzeszinski
et al., 2014; Latreille et al., 2014; Pan et al., 2014; Stickel et al.,
2014; Cushing et al., 2015; Jin et al., 2015; Kosaka et al., 2015;
Kramer et al., 2015; Li et al., 2015a,b,c; Parchem et al., 2015;
Sullivan et al., 2015; Sun et al., 2015; Tung et al., 2015; Xu et al.,
2015; Yan et al., 2015; Zhang et al., 2015). Our analysis showed
that 48% target genes are predominantly regulated by translation
repression (76/159), 29% are regulated mainly by mRNA
degradation (46/159), and 23% are regulated by both (37/159)
(Figure 1). It is still unclear what determines the dominant
mode of miRNA mechanism of action. As most of these
studies measured target gene mRNA and protein levels under
steady-state conditions, we speculate that differences in miRNA
mechanism of action are not solely determined by the expression
kinetics of miRNA or target mRNAs (Bazzini et al., 2012; Béthune
et al., 2012; Djuranovic et al., 2012), but are instead attributed
to cell type-, target mRNA-, or even miRNA-specific factors.
Interestingly, almost all target genes identified in developing
cells or tissues are mainly regulated by mRNA degradation,
such as day 0 or day 2.5 cardiac cells (Heidersbach et al.,
2013; Wei et al., 2014), embryonic stem cell-derived neurons
(Tung et al., 2015), thymocytes (Belkaya et al., 2013; Henao-
Mejia et al., 2013; Burger et al., 2014), bone marrow cells
(Song et al., 2013), embryonic heart (Wystub et al., 2013;
Liang et al., 2015), embryonic yolk sac (Wang et al., 2008),
embryonic and neonatal epithelium (Ahmed et al., 2014), and
fetal liver (Patrick et al., 2010). This is in sharp contrast to
target genes identified in terminally differentiated cells, which
are predominantly regulated by translation repression. It is
conceivable that mRNA degradation gets rid of target gene
mRNAs in a non-reversible way and provides an efficient
way for cell fate determination, while translation repression is
immediate, transient, and reversible, which is more suitable for
differentiated cells to respond to environmental stresses. Our
analysis also suggests miRNA-specific functional consequences.
Several groups independently observed that target genes of miR-
17∼92 (Lu et al., 2007; Shan et al., 2009; Jiang et al., 2011;
Bian et al., 2013; Danielson et al., 2013; Jin et al., 2015), miR-
214 (Aurora et al., 2012; Wang et al., 2013b; Li et al., 2015b),
miR-143/145 (Boettger et al., 2009; Jordan et al., 2011; Caruso
et al., 2012; Dahan et al., 2014), and miR-146 (Boldin et al.,
2011; Guo et al., 2013; Stickel et al., 2014) tend to be regulated
at the translational level, but target genes of miR-122 (Hsu
et al., 2012; Tsai et al., 2012), miR-140 (Miyaki et al., 2010;
Nakamura et al., 2011) and miR-142 (Chapnik et al., 2014;
Kramer et al., 2015; Sun et al., 2015) are often regulated bymRNA
degradation. Interestingly, among miR-155 target genes, some
are predominantly regulated by translation repression, some are
mainly regulated by mRNA degradation, while the others are
regulated by both mechanisms (Vigorito et al., 2007; Dorsett
et al., 2008; Lu et al., 2009, 2014; O’Connell et al., 2009, 2010;
Dudda et al., 2013; Escobar et al., 2014; Hu et al., 2014; Jin et al.,
2015;Wang et al., 2015a), suggesting that different target genes of
the same miRNA can be regulated through different mechanisms
even in the same cell. It is a tempting possibility that cis-elements
FIGURE 1 | Contribution of translation repression and mRNA
degradation to miRNA regulation of target gene expression in primary
cells and tissues frommiRNAmutant mice. Number in parentheses
indicates the number of genes in each category. See also Table S1 for detailed
information.
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in mature miRNAs and target mRNAs determine the mechanism
of miRNA action. Future investigation is warranted to identify
these cis-elements, if they exist at all.
From a practical standpoint, measuring target gene protein
levels is preferred to mRNA levels for the purpose of studying
the effect of a miRNA on its target genes. Even for target genes
predominantly regulated by mRNA degradation, the miRNA
effect can still be captured by measuring their protein abundance.
In the same vein, translatome analysis is more appropriate
for measuring the global effect of a miRNA on its target
genes, while transcriptome analysis often failed to identify any
significant effect of miRNA deletion on its target genes, despite
the obvious functional consequences in mutant mice (Matkovich
et al., 2010; Boldin et al., 2011; Jiang et al., 2011; Agudo et al.,
2014; Sullivan et al., 2015; Yuan et al., 2015). In the broader
context of gene expression regulation, accumulating evidence
shows that proteome and transcriptome are not sufficiently
correlated to act as proxies for each other (Payne, 2015). miRNA-
mediated translation regulation may play an important role
in the de-coupling of translatome from transcriptome. We
speculate that miRNAs emerged during evolution to increase
the complexity of gene regulation, thereby contributing to the
diversity of organisms.
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